Choose the experimental features you want to try

This document is an excerpt from the EUR-Lex website

Document 62019TA0333

    Case T-333/19: Judgment of the General Court of 28 May 2020 — Ntolas v EUIPO — General Nutrition Investment (GN GENETIC NUTRITION LABORATORIES) (EU trade mark — Opposition proceedings — Application for EU figurative mark GN GENETIC NUTRITION LABORATORIES — Earlier EU word mark GNC — Relative ground for refusal — Likelihood of confusion — Article 8(1)(b) of Regulation (EU) 2017/1001)

    IO C 230, 13.7.2020, p. 32–33 (BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

    13.7.2020   

    EN

    Official Journal of the European Union

    C 230/32


    Judgment of the General Court of 28 May 2020 — Ntolas v EUIPO — General Nutrition Investment (GN GENETIC NUTRITION LABORATORIES)

    (Case T-333/19) (1)

    (EU trade mark - Opposition proceedings - Application for EU figurative mark GN GENETIC NUTRITION LABORATORIES - Earlier EU word mark GNC - Relative ground for refusal - Likelihood of confusion - Article 8(1)(b) of Regulation (EU) 2017/1001)

    (2020/C 230/40)

    Language of the case: English

    Parties

    Applicant: Christos Ntolas (Wuppertal, Germany) (represented by: C. Renger, lawyer)

    Defendant: European Union Intellectual Property Office (represented by: P. Sipos, acting as Agent)

    Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: General Nutrition Investment Co. (Wilmington, Delaware, United States) (represented by: M. Rijsdijk, lawyer)

    Re:

    Action brought against the decision of the Fifth Board of Appeal of EUIPO of 11 March 2019 (Case R 1343/2017-5), relating to opposition proceedings between General Nutrition Investment and Mr Ntolas.

    Operative part of the judgment

    The Court:

    1.

    Dismisses the action;

    2.

    Orders Mr Christos Ntolas to bear his own costs and to pay those incurred by the European Union Intellectual Property Office (EUIPO) and by General Nutrition Investment Co.


    (1)  OJ C 246, 22.7.2019.


    Top